Vaccine Adjuvants Market 2027 By Product Type, Route of Administration, Application and Geography | The Insight Partners

Vaccine Adjuvants Market to 2027 - Global Analysis and Forecasts by Product Type (Particulate, Emulsions, Pathogen, Saponin); Route of Administration (Subcutaneous, Intramuscular, Intranasal, Oral); Application (Research, Commercial) and Geography

Report Code: TIPRE00004430 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Naturally occurring parts of pathogens used as adjuvants can help trigger early non-specific, or innate, immune responses to vaccines. These adjuvants target various receptors inside or on the surface of innate immune cells.

MARKET DYNAMICS
The vaccine adjuvants market is anticipated to grow in the forecast, owing to high prevalence of zoonotic and infectious diseases as well as rising focus of government on immunization programs. In addition, the opportunities from developing economies and research in the field of synthetic vaccines is expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE
The "Global Vaccine Adjuvants Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of vaccine adjuvants market with detailed market segmentation by product type, route of administration, application and geography. The global vaccine adjuvants market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading vaccine adjuvants market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global vaccine adjuvants market is segmented on the basis of by product type, route of administration and application. Based on product type, the market is segmented as, particulate, emulsions, pathogen, and saponin. Based on route of administration, the market is segmented in to subcutaneous, intramuscular, intranasal, and oral. On the basis of application, the vaccine adjuvants market is categorized as per research, and commercial.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global vaccine adjuvants market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The vaccine adjuvants market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting vaccine adjuvants market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the vaccine adjuvants market in these regions.

MARKET PLAYERS
The reports cover key developments in the vaccine adjuvants market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from vaccine adjuvants market are anticipated to lucrative growth opportunities in the future with the rising demand for vaccine adjuvants market in the global market. Below mentioned is the list of few companies engaged in the vaccine adjuvants market.

The report also includes the profiles of key vaccine adjuvants market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • OZ Biosciences
  • Phibro Animal Health Corporation
  • Avanti Polar Lipids
  • InvivoGen
  • Novavax
  • Merck KGaA
  • SPI Pharma
  • SEPPIC
  • CSL Limited
  • Brenntag Biosector A/S
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Vaccine Adjuvants Market - By Product Type
1.3.2 Vaccine Adjuvants Market - By Route of Administration
1.3.3 Vaccine Adjuvants Market - By Application
1.3.4 Vaccine Adjuvants Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. VACCINE ADJUVANTS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. VACCINE ADJUVANTS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. VACCINE ADJUVANTS MARKET - GLOBAL MARKET ANALYSIS
6.1. VACCINE ADJUVANTS - GLOBAL MARKET OVERVIEW
6.2. VACCINE ADJUVANTS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. VACCINE ADJUVANTS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. PARTICULATE
7.3.1. Overview
7.3.2. Particulate Market Forecast and Analysis
7.4. EMULSIONS
7.4.1. Overview
7.4.2. Emulsions Market Forecast and Analysis
7.5. PATHOGEN
7.5.1. Overview
7.5.2. Pathogen Market Forecast and Analysis
7.6. SAPONIN
7.6.1. Overview
7.6.2. Saponin Market Forecast and Analysis
8. VACCINE ADJUVANTS MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. SUBCUTANEOUS
8.3.1. Overview
8.3.2. Subcutaneous Market Forecast and Analysis
8.4. INTRAMUSCULAR
8.4.1. Overview
8.4.2. Intramuscular Market Forecast and Analysis
8.5. INTRANASAL
8.5.1. Overview
8.5.2. Intranasal Market Forecast and Analysis
8.6. ORAL
8.6.1. Overview
8.6.2. Oral Market Forecast and Analysis
9. VACCINE ADJUVANTS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. RESEARCH
9.3.1. Overview
9.3.2. Research Market Forecast and Analysis
9.4. COMMERCIAL
9.4.1. Overview
9.4.2. Commercial Market Forecast and Analysis
10. VACCINE ADJUVANTS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Vaccine Adjuvants Market Overview
10.1.2 North America Vaccine Adjuvants Market Forecasts and Analysis
10.1.3 North America Vaccine Adjuvants Market Forecasts and Analysis - By Product Type
10.1.4 North America Vaccine Adjuvants Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Vaccine Adjuvants Market Forecasts and Analysis - By Application
10.1.6 North America Vaccine Adjuvants Market Forecasts and Analysis - By Countries
10.1.6.1 United States Vaccine Adjuvants Market
10.1.6.1.1 United States Vaccine Adjuvants Market by Product Type
10.1.6.1.2 United States Vaccine Adjuvants Market by Route of Administration
10.1.6.1.3 United States Vaccine Adjuvants Market by Application
10.1.6.2 Canada Vaccine Adjuvants Market
10.1.6.2.1 Canada Vaccine Adjuvants Market by Product Type
10.1.6.2.2 Canada Vaccine Adjuvants Market by Route of Administration
10.1.6.2.3 Canada Vaccine Adjuvants Market by Application
10.1.6.3 Mexico Vaccine Adjuvants Market
10.1.6.3.1 Mexico Vaccine Adjuvants Market by Product Type
10.1.6.3.2 Mexico Vaccine Adjuvants Market by Route of Administration
10.1.6.3.3 Mexico Vaccine Adjuvants Market by Application
10.2. EUROPE
10.2.1 Europe Vaccine Adjuvants Market Overview
10.2.2 Europe Vaccine Adjuvants Market Forecasts and Analysis
10.2.3 Europe Vaccine Adjuvants Market Forecasts and Analysis - By Product Type
10.2.4 Europe Vaccine Adjuvants Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Vaccine Adjuvants Market Forecasts and Analysis - By Application
10.2.6 Europe Vaccine Adjuvants Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Vaccine Adjuvants Market
10.2.6.1.1 Germany Vaccine Adjuvants Market by Product Type
10.2.6.1.2 Germany Vaccine Adjuvants Market by Route of Administration
10.2.6.1.3 Germany Vaccine Adjuvants Market by Application
10.2.6.2 France Vaccine Adjuvants Market
10.2.6.2.1 France Vaccine Adjuvants Market by Product Type
10.2.6.2.2 France Vaccine Adjuvants Market by Route of Administration
10.2.6.2.3 France Vaccine Adjuvants Market by Application
10.2.6.3 Italy Vaccine Adjuvants Market
10.2.6.3.1 Italy Vaccine Adjuvants Market by Product Type
10.2.6.3.2 Italy Vaccine Adjuvants Market by Route of Administration
10.2.6.3.3 Italy Vaccine Adjuvants Market by Application
10.2.6.4 Spain Vaccine Adjuvants Market
10.2.6.4.1 Spain Vaccine Adjuvants Market by Product Type
10.2.6.4.2 Spain Vaccine Adjuvants Market by Route of Administration
10.2.6.4.3 Spain Vaccine Adjuvants Market by Application
10.2.6.5 United Kingdom Vaccine Adjuvants Market
10.2.6.5.1 United Kingdom Vaccine Adjuvants Market by Product Type
10.2.6.5.2 United Kingdom Vaccine Adjuvants Market by Route of Administration
10.2.6.5.3 United Kingdom Vaccine Adjuvants Market by Application
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Vaccine Adjuvants Market Overview
10.3.2 Asia-Pacific Vaccine Adjuvants Market Forecasts and Analysis
10.3.3 Asia-Pacific Vaccine Adjuvants Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific Vaccine Adjuvants Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Vaccine Adjuvants Market Forecasts and Analysis - By Application
10.3.6 Asia-Pacific Vaccine Adjuvants Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Vaccine Adjuvants Market
10.3.6.1.1 Australia Vaccine Adjuvants Market by Product Type
10.3.6.1.2 Australia Vaccine Adjuvants Market by Route of Administration
10.3.6.1.3 Australia Vaccine Adjuvants Market by Application
10.3.6.2 China Vaccine Adjuvants Market
10.3.6.2.1 China Vaccine Adjuvants Market by Product Type
10.3.6.2.2 China Vaccine Adjuvants Market by Route of Administration
10.3.6.2.3 China Vaccine Adjuvants Market by Application
10.3.6.3 India Vaccine Adjuvants Market
10.3.6.3.1 India Vaccine Adjuvants Market by Product Type
10.3.6.3.2 India Vaccine Adjuvants Market by Route of Administration
10.3.6.3.3 India Vaccine Adjuvants Market by Application
10.3.6.4 Japan Vaccine Adjuvants Market
10.3.6.4.1 Japan Vaccine Adjuvants Market by Product Type
10.3.6.4.2 Japan Vaccine Adjuvants Market by Route of Administration
10.3.6.4.3 Japan Vaccine Adjuvants Market by Application
10.3.6.5 South Korea Vaccine Adjuvants Market
10.3.6.5.1 South Korea Vaccine Adjuvants Market by Product Type
10.3.6.5.2 South Korea Vaccine Adjuvants Market by Route of Administration
10.3.6.5.3 South Korea Vaccine Adjuvants Market by Application
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Vaccine Adjuvants Market Overview
10.4.2 Middle East and Africa Vaccine Adjuvants Market Forecasts and Analysis
10.4.3 Middle East and Africa Vaccine Adjuvants Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa Vaccine Adjuvants Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Vaccine Adjuvants Market Forecasts and Analysis - By Application
10.4.6 Middle East and Africa Vaccine Adjuvants Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Vaccine Adjuvants Market
10.4.6.1.1 South Africa Vaccine Adjuvants Market by Product Type
10.4.6.1.2 South Africa Vaccine Adjuvants Market by Route of Administration
10.4.6.1.3 South Africa Vaccine Adjuvants Market by Application
10.4.6.2 Saudi Arabia Vaccine Adjuvants Market
10.4.6.2.1 Saudi Arabia Vaccine Adjuvants Market by Product Type
10.4.6.2.2 Saudi Arabia Vaccine Adjuvants Market by Route of Administration
10.4.6.2.3 Saudi Arabia Vaccine Adjuvants Market by Application
10.4.6.3 U.A.E Vaccine Adjuvants Market
10.4.6.3.1 U.A.E Vaccine Adjuvants Market by Product Type
10.4.6.3.2 U.A.E Vaccine Adjuvants Market by Route of Administration
10.4.6.3.3 U.A.E Vaccine Adjuvants Market by Application
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Vaccine Adjuvants Market Overview
10.5.2 South and Central America Vaccine Adjuvants Market Forecasts and Analysis
10.5.3 South and Central America Vaccine Adjuvants Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America Vaccine Adjuvants Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Vaccine Adjuvants Market Forecasts and Analysis - By Application
10.5.6 South and Central America Vaccine Adjuvants Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Vaccine Adjuvants Market
10.5.6.1.1 Brazil Vaccine Adjuvants Market by Product Type
10.5.6.1.2 Brazil Vaccine Adjuvants Market by Route of Administration
10.5.6.1.3 Brazil Vaccine Adjuvants Market by Application
10.5.6.2 Argentina Vaccine Adjuvants Market
10.5.6.2.1 Argentina Vaccine Adjuvants Market by Product Type
10.5.6.2.2 Argentina Vaccine Adjuvants Market by Route of Administration
10.5.6.2.3 Argentina Vaccine Adjuvants Market by Application
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. VACCINE ADJUVANTS MARKET, KEY COMPANY PROFILES
12.1. OZ BIOSCIENCES
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. PHIBRO ANIMAL HEALTH CORPORATION
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. AVANTI POLAR LIPIDS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. INVIVOGEN
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. NOVAVAX
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MERCK KGAA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. SPI PHARMA
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SEPPIC
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. CSL LIMITED
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. BRENNTAG BIOSECTOR A/S
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. OZ Biosciences
2. Phibro Animal Health Corporation
3. Avanti Polar Lipids
4. InvivoGen
5. Novavax
6. Merck KGaA
7. SPI Pharma
8. SEPPIC
9. CSL Limited
10. Brenntag Biosector A/S